Preventing HIV infection in women: A global health imperative

Clinical Infectious Diseases

Volumn 50, Issue SUPPL. 3, 2010, Pages

  Karim, Quarraisha Abdool ^a,b   Sibeko, Sengeziwe ^a   Baxter, Cheryl ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MICROBICIDE; TENOFOVIR;

ABSTINENCE; AFRICA; AGE DISTRIBUTION; CIRCUMCISION; CONDOM; DISEASE TRANSMISSION; HEALTH CARE ACCESS; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; INFECTION RISK; MIGRATION; MONOGAMY; NONHUMAN; PATIENT COUNSELING; POVERTY; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; REVIEW; SEX DIFFERENCE; SEXUALLY TRANSMITTED DISEASE; WOMEN'S HEALTH;

COMMUNICABLE DISEASE CONTROL; DISEASE OUTBREAKS; FEMALE; HIV INFECTIONS; HUMANS; MALE; RISK FACTORS; WOMEN'S HEALTH;

EID: 77951777304     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/651483     Document Type: Review

References (88)

1. UNAIDS. HIV and AIDS estimates and data, 2001-2007. Report on the global AIDS epidemic. 2008. http://data.unaids.org/pub/GlobalReport/2008/JC1511-GR08- ExecutiveSummary-en.pdf. 3 July 2009.
2. Gouws E, Abdool Karim Q. HIV Infection in South Africa: The evolving epidemic. In: Abdool Karim SS, Abdool Karim Q, eds. HIV/AIDS in South Africa. Cape Town: Cambridge University Press, 2005:48-66.
3. South African Department of Health. National HIV and syphilis antenatal seroprevalence survey in South Africa: 2007. http://www.doh.gov.za. Accessed February 2009.
4. Khan M, Pillay T, Moodley JM, Connolly CA. Maternal mortality associated with tuberculosis-HIV-1 co-infection in Durban, South Africa. AIDS 2001; 15(14):1857-1863. (Pubitemid 32939248)
5. Fawcus SR, van Coeverden de Groot HA, Isaacs S. A 50-year audit of maternal mortality in the Peninsula Maternal and Neonatal Service, Cape Town (1953-2002). BJOG 2005; 112(9):1257-1263.
6. Padian NS, Shiboski SC, Glass SO, Vittinghoff E. Heterosexual transmission of human immunodeficiency virus (HIV) in Northern California: results from a ten-year study. Am J Epidemiol 1997; 146(4): 350-357. (Pubitemid 27355571)
7. Hladik F, McElrath MJ. Setting the stage: host invasion by HIV. Nat Rev Immunol 2008;8(6):447-457. (Pubitemid 351735878)
8. Pettifor AE, van der Straten A, Dunbar MS, Shiboski SC, Padian NS. Early age of first sex: a risk factor for HIV infection among women in Zimbabwe. AIDS 2004; 18(10):1435-1442.
9. Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001;357(9263):1149-1153. (Pubitemid 32378686)
10. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000;342(13):921.
11. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005;191(9):1403-1409.
12. Vittinghoff E, Douglas J, Judson F, McKirnan D, MacQueen K, Buchbinder SP. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol 1999;150(3): 306.
13. Gregson S, Nyamukapa CA, Garnett GP, et al. Sexual mixing patterns and sex-differentials in teenage exposure to HIV infection in rural Zimbabwe. Lancet 2002;359(9321):1896-1903. (Pubitemid 34615768)
14. Shattock RJ, Moore JP. Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol 2003;1(1):25-34.
15. Marx PA, Spira AI, Gettie A, et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med 1996;2(10): 1084-1089. (Pubitemid 26338626)
16. Miller L, Patton DL, Meier A, Thwin SS, Hooton TM, Eschenbach DA. Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol 2000;96(3):431-439.
17. Mauck CK, Callahan MM, Baker J, et al. The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy. Contraception 1999;60(1):15-24. (Pubitemid 29505351)
18. Morrison CS, Turner AN, Jones LB. Highly effective contraception and acquisition of HIV and other sexually transmitted infections. Best Pract Res Clin Obstet Gynaecol 2009;23(2):263-284.
19. Population reference bureau. Family planning worldwide 2008 data sheet. 2008. http://www.prb.org/pdf08/fpds08.pdf. 3 July 2009.
20. Kuhn L, Denny L, Pollack AE, Wright TC. Prevalence of visible disruption of cervical epithelium and cervical ectopy in african women using depo-provera. Contraception 1999;59(6):363-367. (Pubitemid 29430164)
21. Myer L, Kuhn L, Stein ZA, Wright TC, Denny L. Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and biological mechanisms. Lancet Infect Dis 2005;5(12):786-794. (Pubitemid 41688983)
22. Norvell MK, Benrubi GI, Thompson RJ. Investigation of microtrauma after sexual intercourse. J Reprod Med 1984;29(4):269-271.
23. Louv WC, Austin H, Perlman J, Alexander WJ. Oral contraceptive use and the risk of chlamydial and gonococcal infections. Am J Obstet Gynecol 1989;160(2):396-402. (Pubitemid 19065383)
24. WHO Docdsar. Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. 2001. http://www.who.int/ docstore/hiv/GRSTI/who-hiv-aids-2001.02.pdf. 30 June 2009.
25. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999;75(1):3-17.
26. Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet 1998;351(Suppl 3):5-7.
27. Corbett EL, Steketee RW, ter Kuile FO, Latif AS, Kamali A, Hayes RJ. HIV-1/AIDS and the control of other infectious diseases in Africa. Lancet 2002;359(9324):2177-2187.
28. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995;346(8974):530-536.
29. Wawer MJ, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 1999;353(9152): 525-535.
30. Kamali A, Quigley M, Nakiyingi J, et al. Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. Lancet 2003;361(9358):645-652. (Pubitemid 36246546)
31. Gregson S, Adamson S, Papaya S, et al. Impact and process evaluation of integrated community and clinic-based HIV-1 control: a clusterrandomised trial in eastern Zimbabwe. PLoS Med 2007;4(3):el02.
32. Padian NS, van der Straten A, Ramjee G, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 2007;370(9583):251-261. (Pubitemid 47069513)
33. Howell AL, Asin SN, Yeaman GR, Wira CR. HIV-1 infection of the female reproductive tract. Curr HIV/AIDS Rep 2005;2(1):35-38.
34. Yeaman GR, Asin S, Weldon S, et al. Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus-type I. Immunology 2004;113(4):524-533. (Pubitemid 39593371)
35. Haynes BF, Shattock RJ. Critical issues in mucosal immunity for HIV1 vaccine development. J Allergy Clin Immunol 2008;122(1):3-9; quiz, 10-11.
36. Cleland J, Ali MM. Sexual abstinence, contraception, and condom use by young African women: a secondary analysis of survey data. Lancet 2006;368(9549):1788-1793. (Pubitemid 44739026)
37. Shisana O, Simbayi L. Nelson Mandela/HSRC study of HIV/AIDS South African national HIV prevalence, behavioural risks and mass media household survey 2002. Pretoria, South Africa: Human Sciences Research Council, 2002.
38. Gouws E. HIV incidence rates in South Africa. In: Abdool Karim S, Abdool Karim Q, eds. HIV/AIDS in South Africa. Cape Town: Cambridge University Press, 2005:67-78.
39. Pettifor AE, Rees HV, Kleinschmidt I, et al. Young people's sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey. AIDS 2005;19(14):1525-1534. (Pubitemid 41400699)
40. Wellings K, Collumbien M, Slaymaker E, et al. Sexual behaviour in context: a global perspective. Lancet 2006;368(9548):1706-1728. (Pubitemid 46055217)
41. Williams B, Gouws E, Colvin M, Sitas F, Ramjee G, Abdool Karim SS. Patterns of infection: using age prevalence data to understand the epidemic of HIV in South Africa. S Afr J Science 2000; 96(6):305-340.
42. MacPhail C, Williams BG, Campbell C. Relative risk of HIV infection among young men and women in a South African township. lnt J STD AIDS 2002;13(5):331-342.
43. Morris CR, Araba-Owoyele L, Spector SA, Maldonado YA. Disease patterns and survival after acquired immunodeficiency syndrome diagnosis in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1996;15(4):321-328. (Pubitemid 26119272)
44. Nnko S, Boerma JT, Urassa M, Mwaluko G, Zaba B. Secretive females or swaggering males? An assessment of the quality of sexual partnership reporting in rural Tanzania. Soc Sci Med 2004;59(2):299-310. (Pubitemid 38534259)
45. Halperin DT, Epstein H. Concurrent sexual partnerships help to explain Africa's high HIV prevalence: implications for prevention. Lancet 2004;364(9428):4-6. (Pubitemid 38976485)
46. Meyer-Weitz A, Reddy P, Van Den Borne HW, Kok G, Pietersen J. Determinants of multi-partner behaviour of male patients with sexually transmitted diseases in South Africa: implications for interventions, Int J Men Health 2003;2(2):149-162.
47. Mnyika KS, Klepp K-I, Kvale G, Ole KN. Determinants of high-risk sexual behaviour and condom use among adults in the Arusha region, Tanzania. Int J STD AIDS 1997;8:176-183. (Pubitemid 27128155)
48. Demographic Health Survey. 2005. http://www.measuredhs.com/. January 2008.
49. Goldstein S, Usdin S, Scheepers E, Japhet G. Communicating HIV and AIDS, what works? A report on the impact evaluation of Soul City's fourth series. J Health Commun 2005;10(5):465-483. (Pubitemid 41523832)
50. Eaton L, Flisher AJ, Aaro LE. Unsafe sexual behaviour in South African youth. Soc Sci Med 2003;56(1):149-165. (Pubitemid 35341674)
51. Hoffman S, O'Sullivan LF, Harrison A, Dolezal C, Monroe-Wise A. HIV risk behaviors and the context of sexual coercion in young adults' sexual interactions: results from a diary study in rural South Africa. Sex Transm Dis 2006; 33(1):52-58. (Pubitemid 43042822)
52. Maharaj P, Cleland J. Condoms become the norm in the sexual culture of college students in Durban, South Africa. Reprod Health Matters 2006;14(28):104-112. (Pubitemid 44708759)
53. Simbayi LC, Chauveau J, Shisana O. Behavioural responses of South African youth to the HIV/AIDS epidemic: a nationwide survey. AIDS Care 2004;16(5):605-618. (Pubitemid 38918093)
54. Abdool Karim S, Abdool Karim Q. The evolving HIV epidemic in South Africa. Int J Epidemiol 2002;31:37-40. (Pubitemid 34284897)
55. Rosengard C, Adler NE, Gurvey JE, et al. Protective role of health values in adolescents' future intentions to use condoms. J Adolesc Health 2001;29(3):200-207. (Pubitemid 32755797)
56. Worth D. Sexual decision-making and AIDS: why condom promotion among vulnerable women is likely to fail. Studies in family planning 1989; 20(6 Pt 1):297-307.
57. Morojele NK, Brook JS, Kachieng'a MA. Perceptions of sexual risk behaviours and substance abuse among adolescents in South Africa: a qualitative investigation. AIDS Care 2006;18(3):215-219.
58. Buga GA, Amoko DH, Ncayiyana DJ. Sexual behaviour, contraceptive practice and reproductive health among school adolescents in rural Transkei. S Afr Med J 1996; 86:523-527.
59. Reddy P, Meyer-Weitz A, van den Borne B, Kok G. Determinants of condom-use behaviour among STD clinic attenders in South Africa, Int J STD AIDS 2000;11(8):521-530. (Pubitemid 30614394)
60. Varga CA. Sexual decision-making and negotiation in the midst of AIDS: youth in KwaZulu-Natal South Africa. Health Trans Rev 1997;7(Suppl 3):45-67.
61. Boer H, Mashamba M.T. Psychosocial correlates of HIV protection motivation among black adolescents in Venda, South Africa. AIDS Educ Prev 2005;17(6):590-602. (Pubitemid 43061823)
62. Harrison A, Xaba N, Kunene P. Understanding safe sex: gender narratives of HIV and pregnancy prevention by rural South African schoolgoing youth. Reprod Health Matters 2001;9(17):63-71. (Pubitemid 32971569)
63. MacPhail C, Campbell C. "I think condoms are good but, aai, I hate those things": condom use among adolescents and young people in a Southern African township. Soc Sci Med 2001;52(11):1613-1627.
64. Meyer L. Chapter 10: Barrier Methods. In: Abdool Karim SS, Abdool Karim Q, eds. HIV/AIDS in South Africa. Cape Town: Cambridge University Press, 2005:166-182.
65. Beksinska ME, Rees VH, Mclntyre JA, Wilkinson D. Acceptability of the female condom in different groups of women in South Africa-a multicentred study to inform the national female condom introductory strategy. S Afr Med J 2001;91(8):672-678. (Pubitemid 32816246)
66. The VCT Efficacy Study Group. Efficacy of voluntary HIV-I counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidada: a randomised trial. Lancet 2000;356:103-112.
67. Sweat M, Gregorich S, Sangiwa G, et al. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV1 in Kenya and Tanzania. Lancet 2000;356:113-121. (Pubitemid 30438512)
68. Shisana O, Rehle T, Simbayi LC, et al. South African National HIV prevalence, HIV incidence, behaviour and communication survey. Cape Town: Human Sciences Research Council Press, 2005.
69. Gaillard P, Melis R, Mwanyumba F, et al. Vulnerability of women in an African setting: lessons for mother-to-child HIV transmission prevention programmes. AIDS 2002;16(6):937-939. (Pubitemid 34409023)
70. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 Trial. PLoS Med 2005;2(11):e298. (Pubitemid 41735779)
71. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007;369(9562):657-666.
72. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007;369(9562):643-656. (Pubitemid 46710115)
73. Williams BG, Lloyd-Smith JO, Gouws E, et al. The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med 2006;3(7):e262. (Pubitemid 44125989)
74. Alliance for Microbicide Development, AIDS Vaccine and Advocacy Coalition. April 2009 Pipeline Update. http://www.avac.Org/ht/d/sp/i/353/pid/ 353. Accessed 3 March 2010.
75. Abdool Karim SS, Coletti A, Richardson B, et al. Safety and effectiveness of vaginal microbicides buffergel and 0.5% PRO 2000/5 gel for the prevention of HIV infection in women: results of the HPTN 035 trial. In: Program and abstracts of the 16th Conference on Retroviruses and Opportunistic Infections (Montreal). 2009. Abstract 48LB.
76. Ramjee G. Female sex workers. In: Abdool Karim SS, Abdool Karim Q, eds. HIV/AIDS in South Africa. Cape Town: Cambridge University Press, 2005:285-297.
77. Gupta GR, Weiss E, Whelan D. Male-female inequalities result in submission to high-risk sex in many societies. Special report: women and HIV. AIDS Analysis Africa 1995;5(4):8-9.
78. Abdool Karim Q, Abdool Karim SS, Soldan K, Zondi M. Reducing the risk of HIV infection among South African sex workers: socieconomic and gender barriers. Am J Pub Health 1995;85:1521-1525.
79. Abdool Karim Q, Abdool Karim SS, Nkomokazi J. Sexual behaviour and knowledge of AIDS among urban black mothers: implications for AIDS intervention programmes. S Afr Med J 1991;80(7):340-343.
80. Lurie M. Migration and AIDS in southern Africa: a review. S Afr J Science 2000;96(6):343-347.
81. Jochelson K, Mothibeli M, Leger JP. Human immunodeficiency virus and migrant labor in South Africa. Int J Health Serv 1991;21(1): 157-173.
82. Jewkes RK, Levin JB, Penn-Kekana LA. Gender inequalities, intimate partner violence and HIV preventive practices: findings of a South African cross-sectional study. Soc Sci Med 2003;56(1):125-134.
83. Abdool Karim Q. Heterosexual transmission of HIV - the importance of a gendered perspective in HIV prevention. In: Abdool Karim SS, Abdool Karim Q, eds. HIV/AIDS in South Africa. Cape Town: Cambridge University Press, 2005:243-261.
84. Lurie M, Williams BG, Zuma K, et al. The impact of migration on HIV-1 transmission in South Africa: a study of migrant and nonmigrant men and their partners. Sex Transm Dis 2003;30:149-156. (Pubitemid 36184364)
85. Colvin M, Abdool Karim SS, Wilkinson D. Migration and AIDS. Lancet 1995;346(8985):1303-1304.
86. Volpp KG, Troxel AB, Pauly MV, et al. A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med 2009; 360(7):699-709.
87. Fernald LC, Hou X, Gertler PJ. Oportunidades program participation and body mass index, blood pressure, and self-reported health in Mexican adults. Prev Chronic Dis 2008;5(3):A81.
88. Fernald LC, Gertler PJ, Neufeld LM. Role of cash in conditional cash transfer programmes for child health, growth, and development: an analysis of Mexico's Oportunidades. Lancet 2008;371(9615):828-837.